Randomized Controlled Trial of Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

Orthopedic wrist procedures often cause significant postoperative pain. A supraclavicular nerve block is an effective and proven method to help reduce postoperative pain and decrease opioid use around the time of upper extremity surgery. Liposomal bupivacaine (Exparel) has been approved for use around the brachial plexus, but its analgesic efficacy has limited data. The investigators' goal is to evaluate the effectiveness of Exparel as compared to plain bupivacaine. The investigators hope to ensure the quality of pain control around the time of distal radius fracture repair and reduce the variability of care at the investigators institution by prospectively and rigorously collecting perioperative data during this study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Age greater than or equal to 18

• Scheduled for orthopedic wrist surgery at University of North Carolina at Chapel Hill.

Locations
United States
North Carolina
UNC Chapel Hill
RECRUITING
Chapel Hill
Contact Information
Primary
Jay Schoenherr, MD
jay_schoenherr@med.unc.edu
9199515062
Time Frame
Start Date: 2024-04-10
Estimated Completion Date: 2026-05
Participants
Target number of participants: 100
Treatments
Experimental: Supraclavicular Liposomal Bupivacaine group
This group will receive the liposomal bupivacaine
Active_comparator: Supraclavicular Plain Bupivacaine group
This group will receive the plain bupivacaine
Related Therapeutic Areas
Sponsors
Leads: University of North Carolina, Chapel Hill

This content was sourced from clinicaltrials.gov